iRhythm Technologies (IRTC) said Wednesday that its 14-day ECG monitoring system, Zio, received regulatory approval from Japan's pharmaceutical and medical device agency.
With regulatory approval, the company said it intends to work with the Japanese Ministry of Health, Labour, and Welfare to reach a reimbursement decision for the Zio ECG monitoring system.
Shares were 1% higher in recent premarket trading.
Price: 73.14, Change: +0.73, Percent Change: +1.01
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.